[Current treatment of pneumococcal meningitis].
Fernández-Viladrich
P
P
Gudiol
F
F
D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D016022:Case-Control Studies; D002555:Cerebrospinal Fluid / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D004352:Drug Resistance, Microbial; D006801:Humans; D008353:Mannitol / Q000627:therapeutic use; D008585:Meningitis, Meningococcal / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D011817:Rabbits; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D008353:Mannitol
Tratamiento actual de la meningitis neumocócica.